Caffeine and the olfactory bulb

Molecular Neurobiology

Volumn 15, Issue 1, 1997, Pages 31-39

  Hadfield, M Gary ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Caffeine; Dependency; Dopamine; Monoamine utilization; Norepinephrine; Olfactory bulb; Serotonin; Stimulation

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; ADENOSINE RECEPTOR; CAFFEINE; CENTRAL STIMULANT AGENT; DOPAMINE; NORADRENALIN; SEROTONIN;

AMYGDALOID NUCLEUS; ANIMAL; ANTIBODY SPECIFICITY; ARTICLE; BRAIN; CORPUS STRIATUM; DRUG EFFECT; HIPPOCAMPUS; HYPOTHALAMUS; INSTITUTE FOR CANCER RESEARCH MOUSE; MALE; METABOLISM; MOUSE; OLFACTORY BULB; PHYSIOLOGY; THALAMUS;

3,4-DIHYDROXYPHENYLACETIC ACID; AMYGDALA; ANIMALS; BRAIN; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; CORPUS STRIATUM; DOPAMINE; HIPPOCAMPUS; HYPOTHALAMUS; MALE; MICE; MICE, INBRED ICR; NOREPINEPHRINE; OLFACTORY BULB; ORGAN SPECIFICITY; RECEPTORS, PURINERGIC P1; SEROTONIN; THALAMUS;

EID: 0031196675     PISSN: 08937648     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02740614     Document Type: Article

References (69)

1. Appel N. M., Mitchell W. M., Contrera, J. F., and De Souza E. B. (1990) Effects of high dose fenfluramine treatment on monoamine uptake sites in rat brain: assessment using quantitative autoradiography. Synapse 6, 33-44.
2. Bassett J. L., Shipley M. T., and Foote S. L. (1992) Localization of corticotropin-releasing factor-like immunoreactivity in monkey olfactory bulb and secondary olfactory areas. J. Comp. Neurol. 316(3), 348-362.
3. Benowitz N. L. (1990) Clinical pharmacology of caffeine. Ann. Rev. Med. 41, 277-288.
4. Braddock S. R., Grafe M. R., and Jones K. L. (1995) Development of the olfactory nerve: its relationship to the craniofacies. Teratology 51(4), 252-256.
5. Calamandrei G., Wilkinson L. S., and Keverne, E. B. (1992) Olfactory recognition of infants in laboratory mice: role of noradrenergic mechanisms. Physiol. Behav. 52(5), 901-907.
6. Chou T. (1992) Wake up and smell the coffee. Caffeine, coffee, and the medical consequences. West. J. Med. 157(5), 544-553.
7. Clans H. L., Moses H. II, and Beaulieu, D. M. (1974) The influence of caffeine on d-amphetamine and apomorphine-induced stereotyped behavior. Life Sci. 14, 1493-1500.
8. Daly J. W. (1993) Mechanism of action of caffeine, in Caffeine, Coffee, and Health (Garattini S., ed.) Raven, New York, pp. 97-150.
9. Elkind A. H. (1991) Drug abuse and headache. Med. Clin. North Am. 75(3), 717-732.
10. Erfurth A., and Schmauss M. (1990) [Adenosine and methylxanthines in the central nervous system - on their significance for psychiatry and neurology] Adenosine und Methylxanthine im Zentralnervensystem - zur Bedeutung für Psychiatrie und Neurologie. Fortschr. Neurol. Psychiatr. 58(4), 137-147.
11. Erinoff L. and Snodgrass S. R. (1986) Effects of adult or neonatal treatment with 6-hydroxydopamine or 5,7-dihydroxytryptamine on locomotor activity, monoamine levels, and response to caffeine. Pharmacol. Biochem. Behav. 24, 1039-1045.
12. Evans S. M. and Griffith R. R. (1992) Caffeine tolerance and choice in humans. Psychopharmacology 108 (1-2), 59-69.
13. Fastbom, J., Pazos, A., Probst, A. and Palacios, J. M. (1987) The distribution of adenosine A1 receptors and 5′-nucleotidase in the human brain: a quantitative autoradiographic study. Neuroscience 22(3), 8130-8126.
14. Ferré S., von Euler G., Johansson B., Fredholm B. B. and Fuxe K. (1991) Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes. Proc. Natl. Acnd. Sci. USA 88, 7238-7241.
15. Fishette G. T., Nock B., and Renner K. (1987) Effects of 5,7- dihydroxy-tryptamine on serotonin 1 and serotonin 2 receptors throughout the rat central nervous system using quantitative autoradiography. Brain Res. 421, 263-279.
16. Fredholm, B. B. (1995) Adenosine, adenosine receptors and the actions of caffeine. Pharmacol. Toxicol. 45, 43-85.
17. Graham K. (1988) Reasons for consumption and heavy caffeine use: generalization of a model based on alcohol research. Addict. Behav. 13(2), 209-214.
18. Griffiths R. R., Bigelow G. E. and Liebson I. A. (1986) Human coffee drinking: reinforcing and physical dependence producing effects of caffeine. J. Pharmacol. Exp. Ther. 239, 416-425.
19. Hadfield M. G. (1995) Cocaine: selective regional effects on central monoamines. Mol. Neurobiol. 11, 47-54.
20. Hadfield M. G., and Milio C. (1987a) HPLC determination of monoamines in rat brain after enzymatic treatment with ascorbate oxidase and sulfatase. J. Liquid Chromatgr. 10, 2047-2052.
21. Hadfield M. G. and Milio C. (1987b) Rimcazole (BW 234 U) and regional monoamine concentrations in mouse brain. Life Sci. 40, 2087-2090.
22. Hadfield M. G. and Milio C. (1987c) Simultaneous HPLC analysis of catecholamines and indoleamines in mouse brain tissue following acetate extractions and treatment with ascorbate oxidase. J. Liquid Chromatgr. 10, 2039-2046.
23. Hadfield, M. G. and Milio C. (1989) Caffeine and regional brain monoamine utilization in mice. Life Sci. 45, 2637-2644.
24. Hadfield M. G. and Milio C. (1992) Cocaine and regional brain monoamines in mice. Pharmacol. Biochem. Behav. 43, 395-403.
25. Hadfield M. G., Crane P., King M. E., Nugent E. A., Milio C., Powell M. D., and Narasimhachari N. (1986a) Determination of 13 catecholamines, indole-amines, metabolites and precursors in less than 20 minutes during a single HPLC run. J. Liquid Chromatogr. 8, 2689-2697.
26. Hadfield M. G., Milio C., and Narasimhachari N. (1986b) HPLC determination of several monoamines in brain tissues of DBA/2 mice during a single run of 20-25 minutes without prior clean-up of samples. J. Chromatogr. 369, 449-453.
27. Hoffman B. J. and Mezey E. (1989) Distribution of serotonin 5-HT 1c receptor mRNA in adult rat brain. FEBS Lett. 247, 453-462.
28. Jack J. E. (1991) Caffeine and Health [Psychopathology]. Academic, New York.
29. Jarvis M. F. and Williams M. (1990) Direct autoradiographic localization of adenosine A2 receptors in the rat brain using the A2-selective agonist, [3H]CGS 21680. Eur. J. Pharmacol. 68(2), 243-246.
30. Jarvis M. F., Jackson R. H., and Williams M. (1989) Autoradiographic characterization of high-affinity adenosine A2 receptors in rat brain. Brain Res. 484, 111-118.
31. Kirch D. G., Taylor T. R., Gerhardt G. A., Benowitz N., Stephen C., Freedman R., and Wyatt R. J. (1990) Effect of chronic caffeine administration on monoamine and monoamine metabolite concentrations in rat brain. Neuropharmacology 29(6), 599-602.
32. Kitatani T., Watanabe Y., and Shibuy T. (1993) Different effects of methylxanthines on central serotonergic postsynaptic neurons in a mouse behavioral model. Pharmacol. Biochem. Behav. 44, 457-461.
33. Koenigsberg H. W., Pollak C. P., and Fine J. (1993) Olfactory hallucinations after the infusion of caffeine during sleep. Am. J. Psychiatr. 150(12), 1897, 1898.
34. Kozlowski L. T., Henningfield J. E., Keenan R. M., Lei H., Leigh G., Jelineck L. C., Pope M. A., and Haertzen C. A. (1993) Patterns of alcohol, cigarette and caffeine and other drug use in two drug abusing populations. J. Subst. Abuse Treat. 10(2), 171-193.
35. Kratskin I. L. (1995) Functional anatomy, central connections, and neurochemistry of the mammalian olfactory bulb, in (Doty R. L., ed.), Handbook of Olfaction and Gustation Marcell Dekker, New York, pp. 103-126.
36. Lee K. S., and Reddington M. (1986) Autoradiographic evidence for multiple CNS binding sites for adenosine derivatives. Neuroscience 19(2), 535-549.
37. Lumia A. R., Teicher M. H., Salchli F., Ayers E., and Possidente B. (1992) Olfactory bulbectomy as a model for agitated hyposerotonergic depression. Brain Res. 587(2), 181-185.
38. Mamounas L. A., Mullen C. A., O'Hearn E., and Molliver M. E. (1991) Dual serotoninergic projections to forebrain in the rat: morphologically distinct 5 HT axon terminals exhibit differential vulnerability to neurotoxic amphetamine derivatives. J. Comp. Neurol. 314(3), 558-568.
39. Martin G. R. and Humphrey, P. P. A. (1994) Receptors for 5-hydroxy-tryptamine: Current perspectives on classification and nomenclature. Neuropharmacology 533, 261-273.
40. McKenna D. J., Maxarali A. J., Hoffman A. J., Nichols D. E., Mathis C. A., and Saavedra, J. M. (1989) Common receptors for hallucinogens in rat brain: a comparative autoradiographic study using [1251]LSD and [1251] DOI, a new psychomimetic radioligand. Brain Res. 476, 45-56.
41. McKenna D. J. and Saavedra J. M. (1987) Autoradiography of LSD and 2,5′dimethoxyphenyl-isopropylamine psychomimetics demonstrates regional, specific cross-displacement in the rat brain. Eur. J. Pharmacol. 142, 313-315.
42. McLean J. H., Darby-King A., Sullivan R. M., and King S. R. (1993) Serotonergic influence on olfactory learning in the neonate rate. Behav. Neural. Biol. 60(2), 152-162.
43. Mestre N., Petter A., and Bons N. (1992) Systematisation of the olfactory bulb efferent projections in a lemurian primate: Microcebus murinus. J. Hirnforsch. 33(2), 173-184.
44. Mick G., Cooper H., and Magnin M. (1993) Retinal projection to the olfactory tubercle and basal telencephalon in primates. J. Comp. Neurol. 327(2), 205-219.
45. Milio C. and Hadfield M. G. (1992) Ethanol alters monoamines in specific brain regions. Brain Res. Bull. 29, 599-603.
46. Minana M. D. and Grisolia S. (1986) Caffeine ingestion by rats increases noradrenaline turnover and results in self-biting. J. Neurochem. 47(3), 728-732.
47. Misra A. L., Vadlamani, N. L., and Pontan R. B. (1986) Effect of caffeine on cocaine locomotor of caffeine on cocaine locomotor stimulant activity in rats. Pharmacol. Biochem. Behav. 24, 761-764.
48. Missak S. S. (1991) Exploring the role of an endogenous caffeine-like substance in the pathogenesis of schizophrenia. Med. Hypotheses 36(2), 157-161.
49. Muller F., and O'Rahilly R. (1989) The human brain at stage 17, including the appearance of the future olfactory bulb and the first amygdaloid nuclei. Anat. Embryol 180(4), 353-369.
50. Nehlig A., Daval J. L., and Debry G. (1992) Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulation effects. Brain Res. Rev. 17(2), 139-170.
51. Pazos A., Cardias R., and Palaces J. M. (1985a) Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors. Brain Res. 346, 205-230.
52. Pazos A., Cardias R., and Palaces, J. M. (1985b) Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. serotonin-2 receptors. Brain Res. 346, 231-249.
53. Perret M., and Schilling A. (1993) Response to short phoroperiod and spontaneous sexual recrudescence in the lesser mouse lemur: role of olfactory bulb removal. J. Endocrinol. 137(3), 511-518.
54. Petersen E. P., Abhold R. H., Camara C. G., Wright J. W. and Harding J.W. (1985) Characterization of angiotensin binding in the African green monkey. Brain Res. 341(1), 139-146.
55. Reith M. E. (1990) 5-HT3 receptor antagonists attenuate cocaine-induced locomotion in mice. Eur. J. Pharmacol. 186(2-3), 327-330.
56. Reyher C. K. (1988) Persistence of the pars externa system of the anterior olfactory nucleus in a microsmatic primate, Callithrix jacchus. Brain Res. 475(1), 169-175.
57. Sanides-Kohlrausch C., and Wahle P. (1991) Distribution and morphology of substance P-immunoreactive structures in the olfactory bulb and olfactory peduncle of the common marmoset (Callithrix jacchus), a primate species. Neurosci. Lett. 131(1), 117-120.
58. Sawynok J. and Yaksh T. L. (1993) Caffeine as an analgesic adjuvant: a review of pharmacology and mechanisms of action. Pharmacol. Rev. 45, 43-85.
59. Schechter M. D. (1977) Caffeine potentiation of amphetamine: implications for hyperkinesis therapy. Pharmacol. Biochem. Behav. 6, 359-361.
60. Senba E., Daddona P. E., and Nagy J. I. (1989) Adenosine deaminase-containing neurons in the olfactory system of the rat during development. Brain Res. Bull. 18(5), 635-648.
61. Shen Y., Monsma F. J. R., Metcalf M. A., Jose P. A., Hamblin M. W., and Sibley, D. R. (1993) Molecular cloning and expression of a 5-hydroxytryptamine 7 serotonin receptor subtype. J. Biol. Chem. 268(24), 18,200-18,204.
62. Shi D., Nikodijevic O., Jacobson K. A., and Daly J. W. (1993) Chronic caffeine alters the density of adenosine, adrenergic, cholinergic, GABA, and serotonin receptors and calcium channels in mouse brain. Cell. Mol. Neurobiol. 13, 247-261.
63. Stoner G. R., Skirboll L. R., Werkman S., and Hommer D. W. (1988) Preferential effects of caffeine on limbic and cortical dopamine systems. Biol. Psychiatr. 23, 761-768.
64. Strain E. C., Mumford G. H., Silverman K., and Griffiths, R. R. (1994) Caffeine dependence syndrome. Evidence from case histories and experimental evaluation. JAMA 272(13), 1043-1048.
65. Waldek B. (1973) Sensitization by caffeine of central catecholamine receptors. J. Neural. Trans. 34, 61-72.
66. White B. C. and Keller G. E. II (1984) Caffeine pretreatment: enhancement and attenuation of d-amphetamine-induced activity. Pharmacol. Biochem. Behav. 20, 383-386.
67. White B. C., Simpson C. C., Adams J. E., and Harleins D., Jr. (1978) Monoamine synthesis and caffeine-induced locomotor activity. Neuropharmacology 17, 511-513.
68. Wise R. A. (1987) The role of reward pathways in the development of drug dependence. Pharmacol. Ther. 35(1-2), 227-263.
69. Wortsman J. and Hughes L. F. (1996) Case report: olfactory function in a fertile eunuch with Kallmann syndrome. Am. J. Med. Sci. 311(3), 135-138.